Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma

被引：0
|
作者：
Firsova, Maya [1 ]
Mendeleeva, Larisa [1 ]
Solovev, Maxim [1 ]
Kuzmina, Larisa [1 ]
Julhakyan, Hunan [1 ]
Savchenko, Valeriy [1 ]
机构：
[1] Natl Res Ctr Hematol, Moscow, Russia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
multiple myeloma; allogeneic hematopoietic stem cell transplant; allo-HSCT; high-risk; progression; acute GVHD; transplant-related mortality; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-269
引用
下载
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [41] Progress in hematopoietic stem cell transplantation in multiple myeloma
    Gahrton, S
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (06) : 463 - 470
  • [42] Thalidomide and Hematopoietic Stem Cell Transplantation for Multiple Myeloma
    Rajappa, Senthil
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (02) : 23 - 26
  • [43] Treosulfan plus fludarabine - encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Afram, G.
    Nahi, H.
    Liwing, J.
    Heeg, B.
    Mattsson, J.
    LeBlanc, K.
    Bjorkstrand, B.
    Gahrton, G.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S592 - S592
  • [44] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    G Schilling
    T Hansen
    A Shimoni
    T Zabelina
    J-A Simon-Perez
    N C Gutierrez
    W Bethge
    P Liebisch
    R Schwerdtfeger
    M Bornhäuser
    S Otterstetter
    E M M Penas
    J Dierlamm
    F Ayuk
    D Atanackovic
    U Bacher
    C Bokemeyer
    A Zander
    J S Miguel
    A Nagler
    N Kröger
    Leukemia, 2008, 22 : 1250 - 1255
  • [45] Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Case Report
    Szlauer-Stefanska, Anastazja
    Krawczyk-Kulis, Malgorzata
    Kaminska-Winciorek, Grazyna
    Bobek-Billewicz, Barbara
    Giebel, Sebastian
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2551 - 2553
  • [46] Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Schilling, G.
    Hansen, T.
    Shimoni, A.
    Zabelina, T.
    Simon-Perez, J-A
    Gutierrez, N. C.
    Bethge, W.
    Liebisch, P.
    Schwerdtfeger, R.
    Bornhaeuser, M.
    Otterstetter, S.
    Penas, E. M. M.
    Dierlamm, J.
    Ayuk, F.
    Atanackovic, D.
    Bacher, U.
    Bokemeyer, C.
    Zander, A.
    Miguel, J. S.
    Nagler, A.
    Kroeger, N.
    LEUKEMIA, 2008, 22 (06) : 1250 - 1255
  • [47] The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Bensinger, W. I.
    LEUKEMIA, 2006, 20 (10) : 1683 - 1689
  • [48] Long-Term Outcome After Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Montefusco, V.
    Peccatori, J.
    Grifoni, F.
    Spina, F.
    Olivieri, A.
    Farina, L.
    Dodero, A.
    Milani, R.
    Onida, F.
    Ciceri, F.
    Corradini, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S46 - S46
  • [49] The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    W I Bensinger
    Leukemia, 2006, 20 : 1683 - 1689
  • [50] IS THERE A ROLE FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA : WHO ARE THE BEST CANDITATES AND WHEN?
    Sucak, G.
    Acar, K.
    Cetin, Z.
    Baysal, N. A.
    Yegin, Z. A.
    Suyani, E.
    Aki, Z.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S455 - S455
12345